ESMO 2022

SOPHiA GENETICSTM is excited to be a part of the European Society of Medical Oncology 2022 annual meeting, held in person and virtually in Paris, France from September 9-13. 

You will have the chance to chat with our experts at booth #258 and schedule a demo universal SOPHiA DDM™ Platform.

Join us on September 10 from 17h-19h ​in Hall 5 Room 512​ for a presentation on our CE-IVD certified SOPHiA DDMTM Dx Oncology Applications

Decentralized in vitro diagnostic testing for new biomarkers in ovarian and lung cancer – homologous recombination deficiency (HRD) and RNA fusion detection.

What’s New? CE-IVD Oncology Applications by SOPHiA GENETICS™

Alexander Kurze, PhD  

Senior Director Product Management, SOPHiA GENETICS ​

Evaluation of a low-pass whole genome sequencing-based solution for homologous recombination deficiency detection supported by deep learning algorithms 

Dr. Adrien Buisson 

Praticien Spécialiste des CLCC – UF de Biologie des Tumeurs, Centre Léon Bérard- Cheney  ​

Clinical validation of novel RNA fusion detection for NSCLC with SOPHiA DDMTM Dx RNAtarget Oncology Solution

Prof. Alexander Harlé, PhD 

Biologist/Professor of liquid biopsy and tumor heterogeneity group, Institut de Cancérologie de Lorraine-Alexis Vautrin ​

Enabling clinical workflows in Trusted Research Environments ​

Gaetano Bonifacio, PhD 

Industry Advisor-Healthcare, Microsoft

Disclaimer notice:

The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.
The opinions expressed during this presentation are those of the speaker and may not represent the opinions of SOPHiA GENETICS. SOPHiA GENETICS does not provide support in the validation of custom products for clinical use. SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at[email protected] to obtain the appropriate product information for your country of residence.

Event Date

September 9, 2022 – September 13, 2022

Event Type

In-person

Event Location

Europe

Areas of Interest

Solid Tumor, Hereditary Cancer, BioPharma, Blood Cancer

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.
';